細胞治療の世界市場規模は、2023年に47億4,000万ドルと推定され、2024年から2030年にかけて22.66%のCAGRで成長すると予想されます。細胞治療の市場は、新しい細胞タイプを含むように絶えず成長しており、企業が市場での地位を強化する大きな機会を提供しています。その結果、ここ数年で細胞治療の開発に取り組む企業が飛躍的に増加しています。
目次
Table of Contents
Chapter 1. Cell Therapy Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Therapy Type Segment
1.1.2. Therapeutic Area Segment
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List Of Secondary Sources
1.8. List Of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Cell Therapy Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Landscape Insights
Chapter 3 Cell Therapy Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rise In The Number Of Clinical Studies Pertaining To The Development Of Cellular Therapies
3.2.1.2 Rising Adoption Of Regenerative Medicine
3.2.1.3 Introduction Of Novel Platforms And Technologies
3.2.2 Market Restraint Analysis
3.2.2.1 Ethical Concerns Related To Stem Cell Research
3.2.2.2 Clinical Issues Pertaining To Development & Implementation Of Cell Therapy
3.3 Industry Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTEL Analysis
3.3.3 COVID-19 Impact Analysis
Chapter 4 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis
4.1 Allogeneic Cell Therapy
4.1.1 Global Allogeneic Cell Therapy Market, 2018 - 2030 (USD Billion)
4.1.2 Stem Cell Therapies
4.1.2.1 Global Allogeneic Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Billion)
4.1.2.2 Hematopoeitic Stem Cell Therapies
4.1.2.2.1 Global Allogeneic Cell Therapy Market For Hematopoeitic Stem Cell Therapies, 2018 - 2030 (USD Billion)
4.1.2.3 Mesenchymal Stem Cell Therapies
4.1.2.3.1 Global Allogeneic Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Billion)
4.1.3 Non-Stem Cell Therapies
4.1.3.1 Global Allogeneic Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
4.1.3.2 Keratinocytes & Fibroblast-Based Therapies
4.1.3.2.1 Global Allogeneic Cell Therapy Market For Keratinocytes & Fibroblast-Based Therapies, 2018 - 2030 (USD Billion)
4.1.3.3 Others
4.1.3.3.1 Global Allogeneic Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
4.2 Autologous Cell Therapy
4.2.1 Global Autologous Cell Therapy Market, 2018 - 2030 (USD Billion)
4.2.2 Stem Cell Therapy
4.2.2.1 Global Autologous Cell Therapy Market For Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.2.2.2 BM, Blood, & Umbilical Cord-Derived Stem Cells
4.1.2.2.1 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cells, 2018 - 2030 (USD Billion)
4.2.2.3 Adipose Derived Cells
4.1.2.3.1 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Billion)
4.2.2.4 Others
4.2.2.4.1 Global Autologous Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Billion)
4.2.3 Non-Stem Cell Therapy
4.2.3.1 Global Autologous Cell Therapy Market For Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.2.3.2 T-Cell Therapies
4.2.3.2.1 Global Autologous Cell Therapies Market For T-Cell Therapy, 2018 - 2030 (USD Billion)
4.2.4.2.2 CAR-T Cell Therapy
4.2.4.2.2.1 Global Autologous Cell Therapy Market For CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
4.2.4.2.3 T-Cell Receptor (TCR)
4.2.4.2.3.1 Global Autologous Cell Therapy Market For T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
4.2.3.3 Others
4.2.3.3.1 Global Autologous Cell Therapies Market For Other Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
Chapter 5 Cell Therapy Market Categorization: Therapeutic Area Estimates & Trend Analysis
5.1 Cell Therapy Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Global Cell Therapy Market For Oncology Therapies, 2018 - 2030 (USD Million)
5.3 Cardiovascular Disease (CVD)
5.3.1 Global Cell Therapy Market For Cardiovascular Disease (CVD) Therapies, 2018 - 2030 (USD Million)
5.4 Musculoskeletal Disorders
5.4.1 Global Cell Therapy Market For Musculoskeletal Disorders Therapies, 2018 - 2030 (USD Million)
5.5 Dermatology
5.5.1 Global Cell Therapy Market For Dermatology Therapies, 2018 - 2030 (USD Million)
5.6 Others
5.6.1 Global Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Million)
Chapter 6 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis
6.1 North America
6.1.1 North America Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.1.2 U.S.
6.1.2.1 Key Country Dynamics
6.1.2.2 Target Disease Prevalence
6.1.2.3 Competitive Scenario
6.1.2.4 Regulatory Framework
6.1.2.6 U.S. Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.1.3 Canada
6.1.3.1 Key Country Dynamics
6.1.3.2 Target Disease Prevalence
6.1.3.3 Competitive Scenario
6.1.3.4 Regulatory Framework
6.1.3.6 Canada Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2 Europe
6.2.1 Europe Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.2 Germany
6.2.2.1 Key Country Dynamics
6.2.2.2 Target Disease Prevalence
6.2.2.3 Competitive Scenario
6.2.2.4 Regulatory Framework
6.2.2.6 Germany Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.3 UK
6.2.3.1 Key Country Dynamics
6.2.3.2 Target Disease Prevalence
6.2.3.3 Competitive Scenario
6.2.3.4 Regulatory Framework
6.2.3.6 UK Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.4 Switzerland
6.2.4.1 Key Country Dynamics
6.2.4.2 Target Disease Prevalence
6.2.4.3 Competitive Scenario
6.2.4.4 Regulatory Framework
6.2.4.6 Switzerland Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3 Asia Pacific
6.3.1 Asia Pacific Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.2 Japan
6.3.2.1 Target Disease Prevalence
6.3.2.2 Competitive Scenario
6.3.2.3 Regulatory Framework
6.3.2.5 Japan Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3 China
6.3.3.1 Target Disease Prevalence
6.3.3.2 Competitive Scenario
6.3.3.3 Regulatory Framework
6.3.3.5 China Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.4 India
6.3.4.1 Target Disease Prevalence
6.3.4.2 Competitive Scenario
6.3.4.3 Regulatory Framework
6.3.4.5 India Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.5 South Korea
6.3.5.1 Target Disease Prevalence
6.3.5.2 Competitive Scenario
6.3.5.3 Regulatory Framework
6.3.5.5 South Korea Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Rest Of The World
6.4.1 Rest Of The World Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Categorization
7.2 Strategy Mapping
7.3 Company Market Position Analysis, 2023
7.4 Company Profiles/Listing
7.4.1 Novartis AG
7.4.1.1 Company Overview
7.4.1.4 Financial Performance
7.4.1.3 Product Benchmarking
7.4.1.4 Strategic Initiatives
7.4.2 Gilead Sciences, Inc.
7.4.2.1 Company Overview
7.4.2.2 Financial Performance
7.4.2.3 Product Benchmarking
7.4.2.4 Strategic Initiatives
7.4.3 Bristol-Myers Squibb Company
7.4.3.1 Company Overview
7.4.3.2 Financial Performance
7.4.3.3 Product Benchmarking
7.4.3.4 Strategic Initiatives
7.4.4 Johnson & Johnson Services, Inc
7.4.4.1 Company Overview
7.4.4.2 Financial Performance
7.4.4.3 Product Benchmarking
7.4.4.4 Strategic Initiatives
7.4.5 JCR Pharmaceuticals Co., Ltd.
7.4.5.1 Company Overview
7.4.5.2 Financial Performance
7.4.5.3 Product Benchmarking
7.4.5.4 Strategic Initiatives
7.4.6 JW Therapeutics
7.4.6.1 Company Overview
7.4.6.2 Financial Performance
7.4.6.3 Product Benchmarking
7.4.6.4 Strategic Initiatives
7.4.7 Atara Biotherapeutics
7.4.7.1 Company Overview
7.4.7.2 Financial Performance
7.4.7.3 Product Benchmarking
7.4.7.4 Strategic Initiatives
7.4.8 MEDIPOST
7.4.8.1 Company Overview
7.4.8.2 Financial Performance
7.4.8.3 Product Benchmarking
7.4.8.4 Strategic Initiatives
7.4.9 Anterogen Co., Ltd.
7.4.9.1 Company Overview
7.4.9.2 Financial Performance
7.4.9.3 Product Benchmarking
7.4.9.4 Strategic Initiatives
7.4.10 S. BIOMEDICS
7.4.10.1 Company Overview
7.4.10.2 Financial Performance
7.4.10.3 Product Benchmarking
7.4.10.4 Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 Global Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 3 Global Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 4 Global Cell Therapy Market By Region, 2018 - 2030 (USD Million)
Table 5 North America Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 6 North America Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 7 North America Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 8 U.S. Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 9 U.S. Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 10 Canada Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 11 Canada Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 12 Europe Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 13 Europe Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 14 Europe Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 15 Germany Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 16 Germany Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 17 UK Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 18 UK Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 19 Switzerland Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 20 Switzerland Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Cell Therapy Market By Country, 2018 - 2030 (USD Million)
Table 22 Asia Pacific Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 23 Asia Pacific Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 24 China Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 25 China Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 26 Japan Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 27 Japan Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 28 India Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 29 India Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 30 South Korea Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 31 South Korea Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
Table 32 Rest Of The World Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
Table 33 Rest Of The World Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Cell Therapy Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 PESTEL Analysis
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Global Cell Therapy Market: Therapy Type Key Takeaways
Fig. 12 Global Cell Therapy Market: Therapy Type Movement Analysis
Fig. 13 Global Cell Therapy Market For Allogeneic Therapies, 2018 - 2030 (USD Million)
Fig. 14 Global Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 15 Global Cell Therapy Market For Hematopoetic Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 16 Global Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 17 Global Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 18 Global Cell Therapy Market For Keratinocyte & Fibroblast-Based Therapies, 2018 - 2030 (USD Million)
Fig. 19 Global Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 20 Global Cell Therapy Market For Autologous Cell Therapies, 2018 - 2030 (USD Million)
Fig. 21 Global Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 22 Global Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 23 Global Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
Fig. 24 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
Fig. 25 Global Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
Fig. 26 Global Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 27 Global Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
Fig. 28 Global Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
Fig. 29 Global Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
Fig. 30 Global Cell Therapy Market: Therapeutic Area Key Takeaways
Fig. 31 Global Cell Therapy Market: Therapeutic Area Movement Analysis
Fig. 32 Global Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
Fig. 33 Global Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
Fig. 34 Global Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
Fig. 35 Global Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
Fig. 36 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
Fig. 37 Regional Outlook, 2023 & 2030
Fig. 38 North America Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 39 U.S. Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 40 Canada Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 41 Europe Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 42 Germany Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 43 UK Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 44 Switzerland Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 46 Japan Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 47 China Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 48 India Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 49 South Korea Cell Therapy Market, 2018 - 2030 (USD Million)
Fig. 50 Rest Of The World Cell Therapy Market, 2018 - 2030 (USD Million)
